Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Injectable diabetes medicine that also reduces appetite. | Weekly injection (or daily pill) for diabetes and weight loss. |
| Body system | Diabetes & Weight | Diabetes & Weight |
| Drug class | GLP-1 receptor agonists | GLP-1 receptor agonists |
| Supply | Prescription only | Prescription onlyWHO essential medicine |
| Main uses | Type 2 diabetes | Type 2 diabetes, Obesity and overweight with health problems, Reducing heart attack and stroke risk, Kidney disease in type 2 diabetes, MASH (fatty liver inflammation) |
| How it works | Mimics a gut hormone that helps release insulin when blood sugar is high. | Copies a gut hormone that boosts insulin after meals, slows the stomach and makes you feel full. |
| Starts working | — | Appetite falls within days; full effect over months |
| Half-life | — | About 1 week |
| Typical adult dose | Usually 5 micrograms twice daily before meals, increased to 10 micrograms if needed; extended-release dosing differs. | Ozempic: 0.25 mg weekly, increased monthly to 0.5–2 mg. Wegovy: increased over 16 weeks to 2.4 mg weekly. Rybelsus: 3 mg rising to 7–14 mg daily, on an empty stomach with a sip of water. |
| Forms | Injection pen | Weekly pen injection, Daily tablet |
| Common side effects | Nausea, Vomiting, Diarrhoea, Reduced appetite | Nausea, Vomiting, Diarrhoea, Constipation, Reflux, Tiredness |
| Serious side effects | Pancreatitis, Dehydration and kidney injury, Severe allergic reaction | Pancreatitis, Gallstones, Dehydration and kidney injury from vomiting, Worsening diabetic eye disease with rapid sugar falls, Optic nerve damage (NAION, very rare), Aspiration during anaesthesia |
| Don't take if | — | — |
| Alcohol | — | — |
| Pregnancy | Use with cautionThere is limited pregnancy experience; insulin is generally preferred. | Usually avoidedStop at least 2 months before trying to conceive. |
| Breastfeeding | — | — |
| In use since | — | 2017 |
| Brand names | United States: Byetta, Bydureon | United States: Ozempic, Wegovy, RybelsusUnited Kingdom: Ozempic, Wegovy, RybelsusIndia: Ozempic, Wegovy, Rybelsus |
| Legal status | — | — |
| ATC code | A10BJ01 | A10BJ06 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker